中国当代儿科杂志2016，Vol.18Issue(9)：806-811,6.DOI:10.7499/j.issn.1008-8830.2016.09.004
早产儿呼吸暂停药物治疗的研究现状分析
Current research status of drug therapy for apnea of prematurity
摘要
Abstract
ObjectiveTo investigate the current status of studies on drug therapy for apnea of prematurity (AOP) in the past decade in China and abroad, and to describe the research trends in the field.MethodsCNKI and MEDLINE were searched with the key words “apnea of prematurity” and “treatment” for articles published in the past decade (January 2006 to December 2015). The articles were screened and the key words were extracted to establish the co-occurrence matrix.Ucinet 6.2 was used to plot the knowledge map.ResultsA total of 26 Chinese key words and 20 English key words were included. Those in the center of the co-existent knowledge map of Chinses keywords were “preterm infants”, “apnea”, “primary apnea”, “naloxone” and “aminophylline”; while“apnea”, “preterm infants” and “caffeine” located in the central place of the co-existent knowledge map of English keywords.ConclusionsMethylxanthines are still the major drugs for AOP; however, aminophylline is mainly used in China, while caffeine is mainly used in foreign countries. Other drugs such as naltrexone are also used in the clinical treatment of AOP.关键词
呼吸暂停/药物治疗/共词分析/知识图谱/早产儿Key words
Apnea/Drug therapy/Co-word analysis/Knowledge map/Premature infant引用本文复制引用
陈超,舒先孝,杨晓燕,石晶,唐军,母得志..早产儿呼吸暂停药物治疗的研究现状分析[J].中国当代儿科杂志,2016,18(9):806-811,6.基金项目
国家临床重点专科建设项目（1311200003303）；国家自然科学基金重点基金（81330016）；四川省卫生和计划生育委员会科研课题（150104、150107）；四川省医学科研青年创新课题（Q14036）；成都市科技惠民项目（2014-HM01-00058-SP）。 （）
